About 2/3 of all Americans agree that the top health priority is lowering out-of-pocket costs and/or getting more value for their money. One way to address this problem is to use new technologies to reduce the costs associated with chronic diseases like diabetes and heart disease. After all, Americans with one or more chronic diseases account for 90% of the total healthcare spend in the United States. The problem is, how do decision-makers, like payers, providers, and consumers, know which technologies truly meet their needs and which do not?
In this session, the speakers will examine how well current evaluation techniques serve the needs of key decision-makers, like payers, providers, and consumers, as well as provide guidance on how to apply the various techniques during the decision-making process. This session will be based on the SOA research paper 'Closing the Analytical Gap: Peterson Health Technology Assessments and Actuarial Methods'. Two leading-edge analytical techniques, Total Risk Analysis and Value Stacks, will be featured as part of this discussion.